Life-Saving Drugs, Lethal Prices

“Life-Saving Drugs, Lethal Prices.” By Gayle Sulik, Psychology Today.

More than 90 percent of the anticancer agents approved by the FDA from 2005 to 2009 cost more than $20,000 for a 12-week course of treatment. With skyrocketing prices, the oncology drug industry has grown substantially from under $5 billion in 1998 to $19 billion in 2008 to $80 billion in 2012. Market researchers forecast that by 2018 the industry will reach over $100 billion. Huge profit margins and returns on investment attract pharmaceutical investors. But at what cost to patients?

More »

Be Sociable, Share!

Articles & Posts